We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

The Effect of a Preoperative Single-dose Methylprednisolone on the Postoperative Rehabilitation After Abdominal Hysterectomy

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT01106547
First Posted: April 20, 2010
Last Update Posted: October 13, 2011
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by (Responsible Party):
Anna Aabakke, Holbaek Sygehus
  Purpose

The purpose of this study is to evaluate the effect of 125 mg methylprednisolone, given intravenously 60-90 minutes before abdominal surgery,on the postoperative rehabilitation after abdominal hysterectomy.Sodium Chloride is the placebo. The following parameters are registered:

  1. Pain 3, 6 and 24 hours postoperatively and 2-7 days after surgery.
  2. The postoperative use of additional analgesics.
  3. Inflammatory parameters before and after surgery.
  4. Time until mobilization.
  5. Time until discharge.

Condition Intervention Phase
Hysterectomy Methylprednisolone Postoperative Pain Drug: Methylprednisolone 125mg Drug: Sodium Chloride 2 ml Phase 4

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
Primary Purpose: Prevention
Official Title: The Effect of a Preoperative Single-dose Methylprednisolone on the Postoperative Rehabilitation After Abdominal Hysterectomy: A Prospective, Double Blinded, Placebo Controlled Study

Resource links provided by NLM:


Further study details as provided by Anna Aabakke, Holbaek Sygehus:

Primary Outcome Measures:
  • Pain 6 hours postoperatively [ Time Frame: 6 hours postoperatively ]
    Pain registered by a score on a vas-scale from 0-10 during mobilization and during rest 6 hours postoperatively

  • Pain 3 hours postoperatively [ Time Frame: 3 hours postoperatively ]
    Pain registered by a score on a vas-scale from 0-10 during mobilization and during rest 3 hours postoperatively

  • Pain 24 hours postoperatively [ Time Frame: 24 hours postoperatively ]
    Pain registered by a score on a vas-scale from 0-10 during mobilization and during rest 24 hours postoperatively

  • Pain [ Time Frame: 2-7 days postoperatively ]
    Pain registered by a score on a vas-scale from 0-10 during mobilization and during rest once daily from 2nd-7th postoperative day


Secondary Outcome Measures:
  • Use of additional analgesics [ Time Frame: 0-2 days ]
    The use of other analgesics than paracetamol and diclofenac postoperatively - dosage.

  • Postoperative nausea [ Time Frame: until 2 days postoperatively ]
    Numbers of vomits

  • Use of antiemetics [ Time Frame: 0-2 days postoperatively ]
    Dosage of antiemetics during the first 2 days postoperatively

  • Time until mobilization [ Time Frame: 0-2 days ]
  • Time until discharge after surgery [ Time Frame: 0-10 days ]
  • Inflammatory parameters [ Time Frame: 0-24 h preoperatively ]
    CRP measured 0-24 hours preoperatively before injection of project medicine.

  • Adverse effects [ Time Frame: 0-2 days ]
  • Inflammatory parameter [ Time Frame: 1-2 days postoperative ]
    CRP measured at 10am on the first and second postoperative day.


Estimated Enrollment: 55
Study Start Date: August 2009
Study Completion Date: October 2011
Primary Completion Date: September 2011 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: Methylprednisolone Drug: Methylprednisolone 125mg
Single dose 60-90 minutes preoperatively
Other Name: Solu-medrol
Placebo Comparator: placebo/sodium chloride Drug: Sodium Chloride 2 ml
Single dose 60-90 min preoperatively

  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   Female
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • Patients having an abdominal hysterectomy on a benign indication.
  • Patients who speak and understand Danish.
  • Patients who can give informed consent.

Exclusion Criteria:

  • Diabetics
  • Regular use of glucocorticoids, opioids or tranquilizers
  • Regular treatment with immunosuppressives
  • Alcohol or drug abuse
  • Morphine intolerance
  • Age under 18
  • Chronic pain disease eg fibromyalgia, rheumatoid arthritis
  • Malign indication for hysterectomy
  • BMI over 35
  • Decreased kidney function
  • ASA III or IV
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01106547


Locations
Denmark
Department of Gynaechology and Obstetrics, Holbæk Sygehus
Holbæk, Denmark, 4300
Sponsors and Collaborators
Holbaek Sygehus
Investigators
Study Chair: Niels Jørgen Secher, Professor Department of Obstetrics, Hvidovre Hospital
  More Information

Publications:
Lidegaard O, Hammerum MS. Landspatientregisteret til kvalitetssikring i det gynækologiske speciale. 2002.
Danish hysterektomy database - year report 2004.

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Responsible Party: Anna Aabakke, Anna Aabakke, M.D., Holbaek Sygehus
ClinicalTrials.gov Identifier: NCT01106547     History of Changes
Other Study ID Numbers: Hysterektomistudiet
SJ-127 ( Other Identifier: The Danish National Committee on Biomedical Research Ethics )
2010-018448-15 ( EudraCT Number )
First Submitted: April 14, 2010
First Posted: April 20, 2010
Last Update Posted: October 13, 2011
Last Verified: October 2011

Keywords provided by Anna Aabakke, Holbaek Sygehus:
abdominal hysterectomy
glucocorticoids
rehabilitation
postoperative pain
analgetics

Additional relevant MeSH terms:
Pain, Postoperative
Pain
Neurologic Manifestations
Nervous System Diseases
Postoperative Complications
Pathologic Processes
Signs and Symptoms
Prednisolone acetate
Methylprednisolone acetate
Methylprednisolone
Methylprednisolone Hemisuccinate
Prednisolone
Prednisolone hemisuccinate
Prednisolone phosphate
Anti-Inflammatory Agents
Antiemetics
Autonomic Agents
Peripheral Nervous System Agents
Physiological Effects of Drugs
Gastrointestinal Agents
Glucocorticoids
Hormones
Hormones, Hormone Substitutes, and Hormone Antagonists
Neuroprotective Agents
Protective Agents
Antineoplastic Agents, Hormonal
Antineoplastic Agents